Article info
PostScript
Letter
Lack of consensus for usage of β-blockers in end-stage liver disease
- Correspondence to Professor Aleksander Krag, Department of Gastroenterology and Hepatology, Odense University Hospital, Sdr. Boulevard 29, Entrance 126, Odense 5000, Denmark; Aleksander.krag{at}rsyd.dk
Citation
Lack of consensus for usage of β-blockers in end-stage liver disease
Publication history
- Received February 1, 2016
- Revised February 8, 2016
- Accepted February 9, 2016
- First published March 1, 2016.
Online issue publication
May 10, 2016
Article Versions
- Previous version (1 March 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/